Dolly Vance - Net Worth and Insider Trading

Dolly Vance Net Worth

The estimated net worth of Dolly Vance is at least $566 dollars as of 2024-05-12. Dolly Vance is the EVP Corp. Affairs, G.C., Sect. of Rigel Pharmaceuticals Inc and owns about 575 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $566. Details can be seen in Dolly Vance's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dolly Vance has not made any transactions after 2014-12-18 and currently still holds the listed stock(s).

Transaction Summary of Dolly Vance

To

Dolly Vance Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dolly Vance owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of Dolly Vance’s form 4 insider trades.

Insider Ownership Summary of Dolly Vance

Ticker Comapny Transaction Date Type of Owner
RIGL Rigel Pharmaceuticals Inc 2014-12-18 Gen. Counsel and V.P. of I.P.

Dolly Vance Latest Holdings Summary

Dolly Vance currently owns a total of 1 stock. Dolly Vance owns 575 shares of Rigel Pharmaceuticals Inc (RIGL) as of December 18, 2014, with a value of $566.

Latest Holdings of Dolly Vance

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2014-12-18 575 0.98 566

Holding Weightings of Dolly Vance


Dolly Vance Form 4 Trading Tracker

According to the SEC Form 4 filings, Dolly Vance has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 1,000 shares on December 18, 2014, which brought Dolly Vance around $2,220.

Insider Trading History of Dolly Vance

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dolly Vance Trading Performance

GuruFocus tracks the stock performance after each of Dolly Vance's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dolly Vance is 25.68%. GuruFocus also compares Dolly Vance's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dolly Vance within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dolly Vance's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dolly Vance

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.2
Relative Return to S&P 500(%) 10.28

Dolly Vance Ownership Network

Ownership Network List of Dolly Vance

No Data

Ownership Network Relation of Dolly Vance


Dolly Vance Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Dolly Vance is the Gen. Counsel and V.P. of I.P. of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , EVP & Chief Commercial Officer David A Santos , and Sr VP of Bus Dev and Com Ops Raul R Rodriguez .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Dolly Vance made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

Dolly Vance Mailing Address

Above is the net worth, insider trading, and ownership report for Dolly Vance. Currently GuruFocus does not have mailing address information for Dolly Vance.

Discussions on Dolly Vance

No discussions yet.